Carboplatin Injection by Hospira Recalled due to Visible Particulate Matter
The FDA informs Pharmacists, Patients and healthcare professionals that Carboplatin Injection is recalled due to visible particulates identified as Carboplatin crystals that may cause vasculitis, local infarction and thromboembolism. Background of Carboplatin Injection Carboplatin Injection, by Hospira Inc., is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic [...]
Read more
Recent Comments